interferongammaactivated

Interferon gamma-activated refers to cells, most commonly macrophages, that have been stimulated by the cytokine interferon-gamma (IFN-γ). IFN-γ is produced by activated natural killer cells and T helper 1 (Th1) cells in response to intracellular pathogens and vaccines. Activation by IFN-γ drives macrophages toward a classical, or M1, activation state, characterized by enhanced antimicrobial functions and pro-inflammatory cytokine production.

Mechanistically, IFN-γ signaling through its receptor activates the JAK-STAT pathway, upregulating genes involved in antigen presentation (MHC class II and co-stimulatory molecules), lysosome fusion, and production of reactive nitrogen and oxygen species, notably inducible nitric oxide synthase (NOS2). The resulting macrophages display increased phagocytosis, microbial killing, and antigen presentation to T cells, thereby supporting robust Th1 responses.

Physiologically, IFN-γ-activated macrophages play a crucial role in defense against intracellular bacteria, mycobacteria, and certain parasites. They can also contribute to tissue inflammation and damage when regulation is impaired, and they are often contrasted with alternatively activated (M2) macrophages induced by IL-4/IL-13, which promote tissue repair and anti-inflammatory functions.

Regulation and clinical relevance: IFN-γ signaling involves STAT1 and IRF1, with modulation by anti-inflammatory cues such as IL-10. Clinically, IFN-γ has been used as a therapeutic agent in certain genetic immunodeficiencies and chronic granulomatous disease and is studied in cancer immunotherapy; defects in IFN-γ signaling increase susceptibility to severe mycobacterial infections. In research, IFN-γ activation is used to study macrophage function and host defense mechanisms.

---